CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net (loss) income	$ (3,048)	$ 18,539
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depletion, depreciation and accretion	56,624	51,915
Deferred income tax provision (benefit)	0	0
Stock-based compensation, net	(1,070)	2,210
Unrealized gain on derivative contracts	(21,934)	(20,256)
Amortization/accretion of financing related costs	7,615	5,448
Reorganization items, net		(744)
Accrued settlements on derivative contracts	259	4,302
Change in fair value of embedded derivative liability	(2,052)	(1,819)
Other expense (income)	358	(77)
Change in assets and liabilities:
Accounts receivable	15,658	594
Prepaids and other	202	234
Accounts payable and accrued liabilities	(35,023)	18,455
Net cash provided by operating activities	17,589	78,801
Cash flows from investing activities:
Oil and natural gas capital expenditures	(46,288)	(125,465)
Proceeds received from sales of oil and natural gas assets	4,929	332
Other operating property and equipment capital expenditures	(153)	(1,160)
Contract asset	(10,308)
Other	(25)	163
Net cash used in investing activities	(51,845)	(126,130)
Cash flows from financing activities:
Proceeds from borrowings		35,200
Repayments of borrowings	(35,093)	(95)
Payment of deferred financing costs		(2,887)
Proceeds from issuance of preferred stock	94,607
Other	(455)	(432)
Net cash provided by financing activities	59,059	31,786
Net increase (decrease) in cash, cash equivalents and restricted cash	24,803	(15,543)
Cash, cash equivalents and restricted cash at beginning of period	32,816	48,359
Cash, cash equivalents and restricted cash at end of period	57,619	32,816
Supplemental cash flow information:
Cash paid for interest	28,709	19,933
Cash paid for reorganization items		744
Disclosure of non-cash investing and financing activities:
Asset retirement obligations	1,308	3,692
Accrued capital expenditures	(4,381)	$ 14,883
Contract asset costs in accounts payable and accrued liabilities	4,753
Deemed dividends on Series A preferred stock	12,047
Accrued offering costs	$ (119)